HypaHub developed an advanced data and AI platform for multiomic analysis, enabling high-resolution insights across disease biology, biomarker discovery, and drug development.
Our platform integrated scalable bioinformatics, machine learning, and data engineering to support complex research workflows in biotechnology and life sciences.
HypaHub’s intellectual property has been acquired by GaudiBio and is now exclusively developed within their platform.
This transition ensures that the technology and innovations created at HypaHub continue to advance cutting-edge applications in AI-driven biotechnology.
Multiomic data integration and analysis platforms
AI/ML models for biomarker discovery and disease characterization
Scalable bioinformatics pipelines for research and clinical applications